Videos de Experimentos Relacionados
Cuando los farmacéuticos se niegan a dispensar recetas.
1Department of Bioethics, Cleveland Clinic Foundation, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA. txbioethics@yahoo.com
Lancet (London, England)
|April 25, 2006
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Perspectives on Ethical Issues in Neurotechnology Industry-Academia Partnerships: Voices of Industry (Neuro)Ethicists.
AJOB neuroscience·2026
Same author
A Communitarian Ethics Approach to Ambient Intelligence Systems in Healthcare.
The American journal of bioethics : AJOB·2026
Same author
Bioethics in the Courtroom: Sketching Medicine with Integrity.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same author
Clearing the Mist: The Distinct Roles of Transparency and Explainability for Using AI in Drug and Device Development.
Pharmaceutical medicine·2025
Same author
Artificial Intelligence (AI) Facts Labels: An Innovative Disclosure Tool Promoting Patient-Centric Transparency in Healthcare AI Systems.
Journal of medical systems·2025
Same author
Letter to the Editor - Reply to "Advancing AI Ethics Frameworks in Drug Development: Global Applicability, Practical Challenges, and Dynamic Governance".
Therapeutic innovation & regulatory science·2025
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026